Active substances
Cyproterone + Ethinylestradiol
- SFDA 2
- Health Canada 6
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DIANE-35 TAB | 2`,0.035 mg,mg | Coated tablet · Oral use | 21 Blister | SAR 21.90 | NCE · Prescription | BAYER AG | Valid |
| DIANE-35 TAB | 0.035, 2 mg | Coated tablet · Oral use | 21 Blister | SAR 21.90 | NCE · Prescription | BAYER PHARMA AG | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AMB-CYPROTERONE ACETATE / ETHINYL ESTRADIOL | 02564424 | 0.035 MG; 2 MG | TABLET · ORAL | AMBICARE PHARMACEUTICALS INC. |
| CLÉO -35 | 02436736 | 0.035 MG; 2 MG | TABLET · ORAL | ALTIUS HEALTHCARE INC |
| CYESTRA-35 | 02290308 | 0.035 MG; 2 MG | TABLET · ORAL | KNIGHT THERAPEUTICS INC. |
| DIANE-35 | 02233542 | 2 MG; 35 MCG | TABLET · ORAL | BAYER INC |
| TARO-CYPROTERONE/ETHINYL ESTRADIOL | 02425017 | 0.035 MG; 2 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TEVA-CYPROTERONE / ETHINYL ESTRADIOL | 02309556 | 0.035 MG; 2 MG | TABLET · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Co-cyprindiol 2000microgram/35microgram tablets | £7.02 | 63 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.